PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsopen-angle glaucoma
MeSH D005902 - open-angle glaucoma
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D005901:Glaucoma
$
Success rate
D005902: 
Open-angle glaucoma
D006871:Hydrophthalmos
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
3MEpinephrine Medihaler-epi  1982-01-01   
Abbott BiotherapeuticsLidocaine, Epinephrine Lidocaine W/ Epinephrine  1982-01-01   
AbbVieCarteolol Cartrol  1988-12-28   
Bimatoprost, Timolol Ganfort  2006-05-19   
Bimatoprost Lumigan  2001-03-16   
Bimatoprost Durysta 2024-04-30 2020-03-04   
Brimonidine Alphagan P  2001-03-16   
Brimonidine, Timolol Combigan  2007-10-30   
Bimatoprost Latisse 2023-01-15 2008-12-24   
Acella PharmaceuticalsBetaxolol Betaxolol  2009-11-16   
Adamis PharmaceuticalsEpinephrine Symjepi 2036-10-20 2017-06-15   
AkornBetaxolol Betaxolol  2000-06-30   
Timolol Timolol  1997-03-25   
Alcon ResearchLevobetaxolol Betaxon  2000-02-23   
Pilocarpine, Betaxolol Betoptic Pilo  1997-04-17   
Brinzolamide, Brimonidine Simbrinza 2030-06-17 2013-04-19   
Travoprost Travatan  2001-03-16   
Netarsudil Rhopressa 2026-07-11 2017-12-18   
Netarsudil, Latanoprost Rocklatan 2026-07-11 2019-03-12   
Alembic PharmaceuticalsBimatoprost Bimatoprost  2019-04-12   
Dorzolamide Dorzolamide  2019-08-09   
Timolol, Dorzolamide Dorzolamide Timolol  2021-05-04   
Timolol Timolol  2020-10-22   
Travoprost Travoprost  2019-12-20   
Brimonidine Brimonidine  2023-03-29   
Brimonidine, Timolol Brimonidine Timolol  2023-08-25   
AllerganBrimonidine Alphagan  1997-03-13   
Dipivefrin Propine  1982-01-01   
Brinzolamide Brinzolamide  2020-11-27   
Lidocaine, Epinephrine Lidocaine W/ Epinephrine  1982-01-01   
Timolol Timolol  1989-04-11   
1
2
3
4
5
6
...
10
>
Clinical Trials
Historical Success Rate
Phase 1
75%
6/8
Phase 2
65%
11/17
Phase 3
80%
37/46
Approved: 24Overall Success rate: 39%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Abbott Biotherapeutics
1
2
3
4
5
6
7
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use